Website blocks users with error message
Featured

Website blocks users with error message

Trial Moves Jul 18, 2026

Gene Therapy

Website blocks users with error message
Gene Therapy
July 18, 2026

Website blocks users with error message

Heart failure management is shifting as pharmacists take on a larger role. Discover how they...

User blocked from platform after violation
Gene Therapy
July 14, 2026

User blocked from platform after violation

Medicare introduces a $50 monthly copay for GLP-1 weight-loss drugs, offering affordable access to eligible...

User access denied after system block
Gene Therapy
July 11, 2026

User access denied after system block

Learn why bispecific T-cell therapy for multiple myeloma may face access restrictions and how patient...

NF Research

Read our latest NF Research articles.

Pharmacists Offer Practical Tips to Prevent Drink Spiking
NF Research July 2, 2026

Pharmacists Offer Practical Tips to Prevent Drink Spiking

Learn practical drink spiking prevention tips from pharmacists, including how OTC test strips work and...

Recognizing Cataracts Early and Understanding How They Affect Vision
NF Research June 27, 2026

Recognizing Cataracts Early and Understanding How They Affect Vision

Vision changes can happen gradually, making them easy to overlook at first. Many people assume...

Patient Briefs

Trial Moves

All Posts

Website blocks users with error message
Gene Therapy

Website blocks users with error message

Heart failure management is shifting as pharmacists take on a larger role. Discover how they are improving outcomes for patients...

User Blocked After Policy Violation
Trial Moves

User Blocked After Policy Violation

Proton pump inhibitors may reduce the benefit of durvalumab consolidation after chemoradiotherapy for unresectable stage 3 NSCLC, according to a...

User Account Blocked by Social Media Platform
Patient Briefs

User Account Blocked by Social Media Platform

GLP-1 receptor agonists can interact with oral chemotherapy, jeopardizing treatment effectiveness for diabetes and weight loss patients using glp-1 agents.

Users encounter access denial on websites
Trial Moves

Users encounter access denial on websites

President Trump directs CMS to allocate $10 billion for rural health transformation under the One Big Beautiful Bill Act of...

User Account Blocked by Social Media Platform
Tumor Watch

User Account Blocked by Social Media Platform

New data on schizophrenia treatment options with subcutaneous olanzapine formulation show promise for people with schizophrenia.

User blocked from platform after violation
Gene Therapy

User blocked from platform after violation

Medicare introduces a $50 monthly copay for GLP-1 weight-loss drugs, offering affordable access to eligible beneficiaries starting July 2026.

Web users blocked from certain sites
Patient Briefs

Web users blocked from certain sites

FDA approves Leqembi home administration. Learn about the new starting dosage regimen for subcutaneous lecanemab treatment.

User Receives Unexpected Block Notification
NF Research

User Receives Unexpected Block Notification

Explore the 2026 pulmonary embolism guidelines released by the American Heart Association and ACC, detailing severity categories and treatment strategies...

User access denied after system block
Gene Therapy

User access denied after system block

Learn why bispecific T-cell therapy for multiple myeloma may face access restrictions and how patient education can improve treatment outcomes.

Account Blocked After Policy Violation
Tumor Watch

Account Blocked After Policy Violation

Pharmacist CGM clinics improve diabetes care with better HbA1c outcomes, as a new scoping review shows the impact of pharmacist‑run...

Show More →